Literature DB >> 17389266

Bioenergetic and functional consequences of bone marrow-derived multipotent progenitor cell transplantation in hearts with postinfarction left ventricular remodeling.

Lepeng Zeng1, Qingsong Hu, Xiaohong Wang, Abdul Mansoor, Joseph Lee, Julia Feygin, Ge Zhang, Piradeep Suntharalingam, Sherry Boozer, Abner Mhashilkar, Carmelo J Panetta, Cory Swingen, Robert Deans, Arthur H L From, Robert J Bache, Catherine M Verfaillie, Jianyi Zhang.   

Abstract

BACKGROUND: The present study examined whether transplantation of adherent bone marrow-derived stem cells, termed pMultistem, induces neovascularization and cardiomyocyte regeneration that stabilizes bioenergetic and contractile function in the infarct zone and border zone (BZ) after coronary artery occlusion. METHODS AND
RESULTS: Permanent left anterior descending artery occlusion in swine caused left ventricular remodeling with a decrease of ejection fraction from 55+/-5.6% to 30+/-5.4% (magnetic resonance imaging). Four weeks after left anterior descending artery occlusion, BZ myocardium demonstrated profound bioenergetic abnormalities, with a marked decrease in subendocardial phosphocreatine/ATP (31P magnetic resonance spectroscopy; 1.06+/-0.30 in infarcted hearts [n=9] versus 1.90+/-0.15 in normal hearts [n=8; P<0.01]). This abnormality was significantly improved by transplantation of allogeneic pMultistem cells (subendocardial phosphocreatine/ATP to 1.34+/-0.29; n=7; P<0.05). The BZ protein expression of creatine kinase-mt and creatine kinase-m isoforms was significantly reduced in infarcted hearts but recovered significantly in response to cell transplantation. MRI demonstrated that the infarct zone systolic thickening fraction improved significantly from systolic "bulging" in untreated animals with myocardial infarction to active thickening (19.7+/-9.8%, P<0.01), whereas the left ventricular ejection fraction improved to 42.0+/-6.5% (P<0.05 versus myocardial infarction). Only 0.35+/-0.05% donor cells could be detected 4 weeks after left anterior descending artery ligation, independent of cell transplantation with or without immunosuppression with cyclosporine A (with cyclosporine A, n=6; no cyclosporine A, n=7). The fraction of grafted cells that acquired an endothelial or cardiomyocyte phenotype was 3% and approximately 2%, respectively. Patchy spared myocytes in the infarct zone were found only in pMultistem transplanted hearts. Vascular density was significantly higher in both BZ and infarct zone of cell-treated hearts than in untreated myocardial infarction hearts (P<0.05).
CONCLUSIONS: Thus, allogeneic pMultistem improved BZ energetics, regional contractile performance, and global left ventricular ejection fraction. These improvements may have resulted from paracrine effects that include increased vascular density in the BZ and spared myocytes in the infarct zone.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17389266     DOI: 10.1161/CIRCULATIONAHA.106.659730

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  109 in total

Review 1.  Stem cell therapy for ischemic heart disease.

Authors:  Mohammad Nurulqadr Jameel; Jianyi Zhang
Journal:  Antioxid Redox Signal       Date:  2010-10-28       Impact factor: 8.401

2.  Long-term preservation of myocardial energetic in chronic hibernating myocardium.

Authors:  Mohammad Nurulqadr Jameel; Qinglu Li; Abdul Mansoor; Qiang Xiong; Cory Swingen; Jianyi Zhang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-12-03       Impact factor: 4.733

3.  Bioenergetic and functional consequences of cellular therapy: activation of endogenous cardiovascular progenitor cells.

Authors:  Qiang Xiong; Lei Ye; Pengyuan Zhang; Michael Lepley; Cory Swingen; Liying Zhang; Dan S Kaufman; Jianyi Zhang
Journal:  Circ Res       Date:  2012-06-21       Impact factor: 17.367

4.  Long-term functional improvement and gene expression changes after bone marrow-derived multipotent progenitor cell transplantation in myocardial infarction.

Authors:  Mohammad Nurulqadr Jameel; Qinglu Li; Abdul Mansoor; Xiong Qiang; Aaron Sarver; Xiaohong Wang; Cory Swingen; Jianyi Zhang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-02-19       Impact factor: 4.733

Review 5.  Stem cell therapy: MRI guidance and monitoring.

Authors:  Dara L Kraitchman; Wesley D Gilson; Christine H Lorenz
Journal:  J Magn Reson Imaging       Date:  2008-02       Impact factor: 4.813

Review 6.  Adhesion proteins, stem cells, and arrhythmogenesis.

Authors:  Nikki Gillum; Narine Sarvazyan
Journal:  Cardiovasc Toxicol       Date:  2008-01-05       Impact factor: 3.231

Review 7.  Cell therapy for heart failure: a comprehensive overview of experimental and clinical studies, current challenges, and future directions.

Authors:  Santosh K Sanganalmath; Roberto Bolli
Journal:  Circ Res       Date:  2013-08-30       Impact factor: 17.367

8.  Fibrin patch-based insulin-like growth factor-1 gene-modified stem cell transplantation repairs ischemic myocardium.

Authors:  Jun Li; Kai Zhu; Shan Yang; Yulin Wang; Changfa Guo; Kanhua Yin; Chunsheng Wang; Hao Lai
Journal:  Exp Biol Med (Maywood)       Date:  2015-03-11

9.  Enhanced effect of combining human cardiac stem cells and bone marrow mesenchymal stem cells to reduce infarct size and to restore cardiac function after myocardial infarction.

Authors:  Adam R Williams; Konstantinos E Hatzistergos; Benjamin Addicott; Fred McCall; Decio Carvalho; Viky Suncion; Azorides R Morales; Jose Da Silva; Mark A Sussman; Alan W Heldman; Joshua M Hare
Journal:  Circulation       Date:  2012-12-05       Impact factor: 29.690

Review 10.  Cardiogenic differentiation and transdifferentiation of progenitor cells.

Authors:  Hans Reinecke; Elina Minami; Wei-Zhong Zhu; Michael A Laflamme
Journal:  Circ Res       Date:  2008-11-07       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.